|
|
||||||||
The FASEB Journal, Vol 6, 2859-2863, Copyright © 1992 by The Federation of American Societies for Experimental Biology
RESEARCH COMMUNICATIONS |
PJ Bosma, JR Chowdhury, TJ Huang, P Lahiri, RP Elferink, HH Van Es, M Lederstein, PF Whitington, PL Jansen and NR Chowdhury
Department of Gastroenterology and Liver Diseases, Academic Medical Center, Amsterdam, The Netherlands.
Crigler-Najjar syndrome, type I (CN-I) is a potentially lethal disorder characterized by severe unconjugated hyperbilirubinemia resulting from a recessively inherited deficiency of hepatic UDP-glucuronosyl- transferase (UGT) activity toward bilirubin (B-UGT). Two forms of B-UGT exist in human liver. mRNAs for these two forms and that for another isoform with activity toward simple phenols (P-UGT) have unique 5' regions, but their 3' regions are identical. The three mRNA species are derived from a single locus; the unique 5' regions are encoded by single unique exons and the identical 3' regions consist of four consecutive exons that are shared by all three isoforms. In this paper, we determined genetic lesions in two CN-I patients with deficiency of hepatic B-UGT and P-UGT activities. In one patient, there was a C----T substitution in exon 4 (common region) predicting the substitution of a serine residue with a phenylalanine residue; this mutation was present in the identical region of B-UGT and P-UGT mRNAs. In the other patient, a C----T substitution in exon 2 (common region) of the B-UGT/P-UGT locus resulted in a premature stop codon. This exon (132 nt) was absent in heptic B-UGT and P-UGT mRNAs of this patient due to exon skipping during pre-mRNA processing. Sequence abnormality of three distinct mRNA species explains the abnormality of multiple UGT isoforms in these patients. Presence of identical abnormalities in the common regions of the three mRNAs is consistent with the finding that the common 3' regions of the two B-UGT mRNAs and the P-UGT mRNA are encoded by four shared exons.
This article has been cited by other articles:
![]() |
M. D'Apolito, A. Marrone, V. Servedio, P. Vajro, L. De Falco, and A. Iolascon Seven novel mutations of the UGT1A1 gene in patients with unconjugated hyperbilirubinemia Haematologica, January 1, 2007; 92(1): 133 - 134. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-S. Ki, K.-A Lee, S.-Y. Lee, H.-J. Kim, S. S. Cho, J.-H. Park, S. Cho, K. M. Sohn, and J.-W. Kim Haplotype Structure of the UDP-Glucuronosyltransferase 1A1 (UGT1A1) Gene and Its Relationship to Serum Total Bilirubin Concentration in a Male Korean Population Clin. Chem., December 1, 2003; 49(12): 2078 - 2081. [Full Text] [PDF] |
||||
![]() |
R. B. Ewesuedo, L. Iyer, S. Das, A. Koenig, S. Mani, N. J. Vogelzang, R. L. Schilsky, W. Brenckman, and M. J. Ratain Phase I Clinical and Pharmacogenetic Study of Weekly TAS-103 in Patients With Advanced Cancer J. Clin. Oncol., April 1, 2001; 19(7): 2084 - 2090. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. J. Worman Molecular biological methods in diagnosis and treatment of liver diseases Clin. Chem., August 1, 1997; 43(8): 1476 - 1486. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Bosma, J. R. Chowdhury, C. Bakker, S. Gantla, A. de Boer, B. A. Oostra, D. Lindhout, G. N.J. Tytgat, P. L.M. Jansen, R. P.J. O. Elferink, et al. The Genetic Basis of the Reduced Expression of Bilirubin UDP-Glucuronosyltransferase 1 in Gilbert's Syndrome N. Engl. J. Med., November 2, 1995; 333(18): 1171 - 1175. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ciotti, M. T. Yeatman, R. J. Sokol, and I. S. Owens Altered Coding for a Strictly Conserved Di-glycine in the Major Bilirubin UDP-glucuronosyltransferase of a Crigler-Najjar Type I Patient J. Biol. Chem., February 17, 1995; 270(7): 3284 - 3291. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |